Merger Arbitrage Strategy Explained for Accredited Investors

TL;DR: Merger arbitrage means buying a takeover target's stock below the announced deal price and collecting the spread when the deal closes. Right now, Warner Bros. Discovery trades around $26.84 against Paramount Skydance's $31.00 cash offer, a spread of roughly 15.5% with a targeted close in September 2026. That spread exists entirely because of regulatory risk: the deal still needs European Commission and UK Competition and Markets Authority sign-off. If it clears, arb buyers pocket the gap. If it breaks, WBD stock could fall back toward a standalone valuation well below $26.84.

According to Warner Bros. Discovery's Form 8-K filed with the SEC, Paramount Skydance agreed on February 27, 2026 to pay $31.00 per share in cash for all outstanding WBD shares, plus a daily "ticking fee" of $0.00277778 per share (capped at $0.25 per 90-day period) if the deal has not closed by September 30, 2026. That single sentence in a merger agreement is the entire foundation of merger arbitrage: a fixed price, a target closing date, and a gap between today's stock price and that fixed price that the market has to price for risk.

How Merger Arbitrage Actually Works

I want to walk you through the mechanics using a real, live deal instead of a hypothetical. Paramount Skydance announced on February 27, 2026 that it would acquire Warner Bros. Discovery for $31.00 per share in an all-cash deal valuing WBD's equity at roughly $81 billion and enterprise value at about $110 billion, according to the joint press release from Paramount's investor relations site. Before the announcement, WBD had been through a bidding process: Paramount's first three offers, made between September and October 2025, came in at $19, $22, and $23.50 per share. WBD's board rejected all three. Netflix then entered as a competing bidder, valuing WBD at roughly $82.7 billion on a stock-for-stock basis. Paramount came back with the winning $31.00 cash bid after Netflix granted a waiver letting the deal proceed.

That negotiation history matters because it explains why the market believed the deal was real. WBD's board unanimously approved the merger agreement. Shareholders voted to approve it on April 23, 2026. The Department of Justice cleared it on antitrust grounds on June 12, 2026, according to reporting that cited public deal disclosures. That is three of the four major hurdles cleared: board approval, shareholder approval, and U.S. antitrust clearance.

Here is the mechanical trade. On June 12, 2026, WBD stock closed at $26.84. The deal pays $31.00 in cash at close. If you buy WBD today at $26.84 and the deal closes at $31.00, you make $4.16 per share, or about 15.5%. If the deal takes three more months to close (the targeted date is September 2026), that 15.5% return compounds to an annualized rate well into the double digits, assuming nothing changes and the deal doesn't slip further. You are not betting on WBD's cable networks or streaming subscriber growth. You are betting on the probability that a signed contract gets fully executed on roughly the timeline management laid out. That's the entire strategy: you're pricing deal-completion risk, not company fundamentals.

The spread doesn't move randomly. It compresses as risk clears and widens as risk resurfaces. Every time a regulator issues an approval, a spread should narrow. Every time a regulator opens a deeper investigation, delays a decision, or signals it wants concessions, the spread should widen, because the market is repricing the odds and the expected holding period simultaneously.

The Spread Economics: Warner Bros. Discovery / Paramount Skydance

Here's what that spread looks like in table form, using the most recent publicly reported figures as of this writing.

Metric	Value
Acquirer	Paramount Skydance Corporation (NASDAQ: PSKY)
Target	Warner Bros. Discovery, Inc. (NASDAQ: WBD)
Deal price	$31.00 per share, all cash, plus capped ticking fee after 9/30/2026
WBD closing price (6/12/2026)	$26.84
Gross spread	$4.16 per share (~15.5%)
Remaining regulatory gates	European Commission (decision extended to 7/22/2026), UK Competition and Markets Authority (decision due 8/7/2026)
Targeted close	Q3 2026 (September)
Reverse termination fee (Paramount pays WBD if deal fails)	$2 billion
Deal announced	February 27, 2026

A 15.5% spread on a deal that already has board approval, shareholder approval, and DOJ clearance is wide by historical standards. For comparison, deals with minimal residual risk typically trade in a 2% to 4% spread window as they approach close. The gap here reflects three specific, identifiable risks. First, the European Commission pushed its provisional decision to July 22, 2026 after Paramount submitted a package of concessions, reportedly including a possible sale of Paramount's film distribution joint venture with Universal Pictures. Second, the UK Competition and Markets Authority still has to weigh in by August 7, with a documented history of demanding behavioral remedies on media deals. Third, the deal's financing structure includes sovereign wealth fund participation from Saudi Arabia, the UAE, and Qatar, which together are slated to hold a combined stake near 38.5% through non-voting shares. That is an unusual structure for a U.S.-listed media company. It creates its own headline risk even though it sits outside the DOJ's core antitrust review. If the EU and UK clear the deal with limited remedies, expect the spread to compress sharply toward the 2% to 4% range as September approaches. If either regulator opens a deeper Phase II-style investigation or demands a larger structural remedy, expect the spread to widen and the timeline to slip into 2027.

What Actually Breaks a Merger Arb Deal

Deal breaks aren't random. They cluster around a short list of causes, and 2025-2026 has produced a live example of every one.

Antitrust and regulatory blocks. The FTC blocked Edwards Lifesciences' proposed $945 million acquisition of JenaValve Technology in January 2026, when U.S. District Judge Rudolph Contreras granted the agency's request for a preliminary injunction, finding a reasonable probability the deal would substantially lessen competition in the market for a specific heart-valve device, according to the FTC's own press release. Edwards and JenaValve terminated the deal rather than fight on. In December 2025, the FTC sued to block Henkel's $725 million acquisition of Liquid Nails from American Industrial Partners, arguing the combination would eliminate the two dominant construction-adhesive brands, according to the FTC's complaint announcement. These aren't isolated incidents. They reflect a specific enforcement posture: this FTC and DOJ have shown a willingness to litigate rather than accept divestiture remedies they consider inadequate, a pattern that started with the Kroger-Albertsons grocery merger block and has continued into 2026.

Court intervention after a deal has already closed. This is the risk most retail investors underestimate. Nexstar completed its roughly $6.2 billion acquisition of TEGNA on March 19, 2026, after securing federal regulatory approvals and paying TEGNA shareholders $22.00 per share in cash. Then a coalition led by DirecTV and eight state attorneys general sued, arguing the combined company's 228 television stations reaching about 80% of U.S. households violated the Sherman Antitrust Act. U.S. District Judge Troy Nunley granted a temporary restraining order, then converted it into a preliminary injunction on April 17, 2026, blocking Nexstar from integrating TEGNA's operations while the case proceeds, according to court filings reported by The Desk. Nexstar has since appealed to the Ninth Circuit. TEGNA shareholders already got paid, so this particular fight is now a corporate-structure and integration risk for Nexstar rather than a live arb spread. But it's a clean illustration that regulatory risk in this cycle doesn't end at deal close. State AGs and private plaintiffs can keep litigating after the check clears.

Financing failures. Not every deal is backed by committed capital the way the WBD transaction is, with $47 billion in equity from the Ellison family and RedBird Capital and $54 billion in debt commitments from Bank of America, Citigroup, and Apollo. When a buyer needs to raise debt in a shaky credit market, or when a stock-and-cash structure depends on the acquirer's own share price holding up, financing risk widens spreads fast. Fox Corporation's proposed $22 billion bid for Roku, announced June 15, 2026, is a live example: Fox shares fell as much as 16.8% on announcement day, the worst single-day move in the S&P 500 that session, on investor concern about how a large new bond raise and equity dilution would work. Roku's stock traded at a roughly 15.9% discount to the $160 headline offer just days after announcement, a spread far wider than deals with clean financing typically carry.

MAC clause disputes. A material adverse change (MAC) clause lets a buyer walk away if the target's business deteriorates sharply between signing and closing. These disputes are rarer than antitrust blocks but tend to erupt during macro shocks, industry-specific shakeouts, or when a buyer has cold feet and looks for any contractual exit. When a MAC dispute becomes public, spreads widen immediately because the market has to price litigation risk on top of ordinary closing risk.

Read the Special Situations Investing guide if you want the broader category merger arb sits inside: event-driven strategies that profit from a specific corporate catalyst rather than market direction.

How Accredited Investors Access Merger Arbitrage

You have three real paths in, and they carry meaningfully different risk and effort profiles.

Direct stock positions. You can buy WBD, or Dominion Energy against NextEra's pending $66.8 billion all-stock bid, or any other announced target, directly through a brokerage account. This gives you full transparency and control, but it also means you're carrying single-deal concentration risk with no diversification. You need to read the actual merger agreement (available on SEC EDGAR, not secondhand summaries) to understand termination fees, MAC clause language, financing conditions, and outside dates before you size a position. Stock-for-stock deals add a layer of complexity: you typically need to short the acquirer's shares in the deal ratio to hedge out equity market risk and isolate the pure spread, which is not something most individual investors are set up to do cleanly.

Merger arbitrage hedge funds. Dedicated risk-arb funds run diversified books across dozens of live deals simultaneously, size positions based on their own probability-of-close models, and actively hedge stock-for-stock transactions. This is the institutional version of the strategy and it's where most of the sophisticated capital sits. Access typically requires accredited or qualified purchaser status, subscription minimums that can run from $100,000 to $1 million or more, and lock-up periods of one to three years with limited redemption windows. For a broader map of how accredited investors get into hedge fund strategies generally, see Hedge Fund Strategies for Accredited Investors.

Liquid alternative mutual funds and ETFs. This is the most accessible route and it doesn't require accredited investor status at all, which is worth knowing even in an accredited-investor-focused publication, because it's often the on-ramp before someone moves into a fund structure. The Merger Fund (MERFX), run by Westchester Capital Management under the Virtus umbrella, has operated since 1989 and holds roughly $2.5 billion in net assets, investing at least 80% of assets in announced merger targets globally. On the ETF side, the AltShares Merger Arbitrage ETF (ARB) tracks the Water Island Merger Arbitrage USD Hedged Index and fully hedges stock-for-stock deals with short positions in the acquirer. The NYLI Merger Arbitrage ETF (MNA) and the ProShares Merger ETF (MRGR) offer similar passive, index-based exposure to a basket of live deals. These vehicles give you instant diversification across dozens of deals and daily liquidity, at the cost of management fees that run higher than a plain-vanilla index fund and returns that get diluted across both strong and weak deals in the basket. For a comparison of this whole access category, see Liquid Alternatives: How to Get Hedge Fund Strategies Without the Lock-Up.

The Return Profile: What to Actually Expect

Merger arbitrage is sold as a low-volatility, bond-like return stream, and in most environments that's fair. AllianceBernstein's research desk noted that the HFRI Event Driven Merger Arbitrage Index was up roughly 8% through the end of September 2025, its strongest first three quarters in years, driven by a lighter-touch regulatory backdrop, faster deal completions, and fewer deal breaks, according to AllianceBernstein's published commentary. That's the normal-environment case: mid to high single digits to low double digits annualized, with low correlation to equity market direction because your return depends on deal completion, not market beta.

But the return distribution is not symmetric. Most deals that close pay out a modest, contractually-defined spread. A handful of deals that break can wipe out years of that accumulated income in a single trading session. When the FTC blocked Edwards-JenaValve, that was a total loss of the deal premium for anyone holding JenaValve stock at the time, with the added risk of the stock gapping down below its pre-announcement level as the market repriced it as a standalone company again. That's the tail risk profile: collect small, steady spreads most of the time, and occasionally eat a double-digit loss on a single position when a deal breaks. It's sometimes described as picking up nickels in front of a bulldozer, and while that's a cliché, the underlying math is real. A portfolio with eight winning positions at 4% each and one broken deal at -20% can still post a positive year, but the variance is lumpy and concentrated in a small number of names.

The Risks, Explicitly

I'll lay these out directly rather than bury them in a footnote.

• Deal-break risk. If Paramount and WBD fail to secure EU or UK clearance, WBD stock could fall well below today's $26.84, because the market would need to reprice the company on a standalone basis, not just unwind the spread. The same logic applies to any single-name arb position: your downside is not the current discount to deal price, it's the gap between the current price and whatever the stock is worth with no deal at all.
• Regulatory and antitrust risk under the current enforcement environment. The FTC and DOJ have shown a documented willingness to litigate rather than settle for divestiture remedies they view as insufficient, evidenced by the Edwards-JenaValve injunction, the Loctite-Liquid Nails lawsuit, and the Nexstar-TEGNA post-closing injunction. At the same time, the DOJ cleared Paramount-WBD relatively quickly and cleared Bio-Techne's $11.3 billion sale to Merck KGaA with a tight ~3% spread, showing enforcement is uneven by sector and deal structure rather than uniformly hostile. Media, healthcare, and any deal that creates a two-to-one or duopoly market structure appear to draw the sharpest scrutiny. Cross-border deals add European Commission and UK CMA review on top of U.S. clearance, which is exactly what's keeping the WBD spread wide today.
• Concentration risk. A handful of merger arb positions in a portfolio is not diversification, it's concentrated single-event risk dressed up as a low-volatility strategy. The funds and ETFs solve this by holding dozens of deals simultaneously. A self-directed investor holding two or three positions has not solved it at all.

For context on how this fits into the current dealmaking cycle overall, see the H1 2026 Private Markets Recap, which covers the broader M&A and deal-activity backdrop driving the current wave of merger arb opportunities.

Frequently Asked Questions

Is merger arbitrage the same as risk arbitrage?
Yes, the terms are used interchangeably. Both describe buying a company's stock after it agrees to be acquired, at a discount to the announced deal price, to profit from the spread closing when the transaction completes.

What happens to my shares if a cash merger deal closes?
In an all-cash deal like Paramount-WBD, your shares are automatically converted into the right to receive the merger consideration in cash, $31.00 per WBD share in this case, at the effective time of the merger, per the Agreement and Plan of Merger filed as an exhibit with the SEC. You don't need to do anything actively. The cash typically lands in your brokerage account within a few business days of closing.

Why would I use a fund instead of just buying the target stock directly?
Diversification and hedging mechanics. A single stock-for-stock deal requires shorting the acquirer's shares in the correct ratio to isolate the spread, which most individual investors can't execute cleanly. A dedicated fund or ETF holds many deals at once, so one deal break doesn't sink the whole position, and the manager or index handles the hedge construction for you.

How do I estimate the annualized return on a merger arb spread?
Divide the dollar spread by the current stock price to get the gross return, then annualize based on the expected time to close. For WBD: a $4.16 spread on a $26.84 stock is 15.5% gross. If the deal closes in roughly three months from a mid-June reference point, that annualizes to a rate well above 15.5%, but only if the deal actually closes on schedule. Any slippage in the timeline, or a deal break, changes that math completely, so treat the annualized figure as a best-case estimate, not a guaranteed yield.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.